Qiming U.S. Ventures Management as of March 31, 2025
Portfolio Holdings for Qiming U.S. Ventures Management
Qiming U.S. Ventures Management holds 6 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tourmaline Bio (TRML) | 48.8 | $11M | 742k | 15.21 | |
| Korro Bio (KRRO) | 27.7 | $6.4M | 368k | 17.41 | |
| Jasper Therapeutics Com New (JSPR) | 17.3 | $4.0M | 929k | 4.30 | |
| Hillevax | 2.3 | $540k | 373k | 1.45 | |
| Ventyx Biosciences (VTYX) | 2.1 | $474k | 412k | 1.15 | |
| Kezar Life Sciences Com New (KZR) | 1.8 | $404k | 83k | 4.88 |
